Your browser is no longer supported. Please, upgrade your browser.
TXMD TherapeuticsMD, Inc. daily Stock Chart
TherapeuticsMD, Inc.
Index- P/E- EPS (ttm)-0.76 Insider Own6.80% Shs Outstand271.46M Perf Week7.91%
Market Cap399.41M Forward P/E- EPS next Y-0.30 Insider Trans-0.50% Shs Float236.97M Perf Month11.11%
Income-193.50M PEG- EPS next Q-0.17 Inst Own68.20% Short Float34.97% Perf Quarter47.06%
Sales58.00M P/S6.89 EPS this Y-21.30% Inst Trans0.06% Short Ratio14.51 Perf Half Y-34.78%
Book/sh-0.17 P/B- EPS next Y51.60% ROA-75.10% Target Price- Perf Year-41.18%
Cash/sh0.64 P/C2.35 EPS next 5Y21.80% ROE- 52W Range0.85 - 4.32 Perf YTD-38.02%
Dividend- P/FCF- EPS past 5Y-14.60% ROI-79.10% 52W High-65.28% Beta2.17
Dividend %- Quick Ratio3.20 Sales past 5Y27.00% Gross Margin85.70% 52W Low75.85% ATR0.13
Employees348 Current Ratio3.40 Sales Q/Q215.40% Oper. Margin- RSI (14)59.86 Volatility9.86% 8.92%
OptionableYes Debt/Eq- EPS Q/Q-27.80% Profit Margin- Rel Volume0.47 Prev Close1.47
ShortableYes LT Debt/Eq- EarningsMay 06 BMO Payout- Avg Volume5.71M Price1.50
Recom2.00 SMA2014.94% SMA5016.89% SMA200-26.54% Volume2,679,649 Change2.04%
May-19-20Downgrade JP Morgan Overweight → Neutral
Dec-02-19Initiated Guggenheim Buy
Oct-17-19Initiated H.C. Wainwright Buy $7
Apr-30-19Resumed Noble Capital Markets Outperform $13
Jun-15-18Initiated JP Morgan Overweight $11
Sep-08-17Initiated Morgan Stanley Equal-Weight $6
Jul-11-17Upgrade Oppenheimer Perform → Outperform
May-09-17Downgrade Oppenheimer Outperform → Perform
Nov-22-16Resumed Jefferies Buy $18
Nov-22-16Initiated Oppenheimer Outperform
Nov-07-16Resumed Guggenheim Buy
Apr-04-16Initiated Goldman Buy $10
Dec-08-15Reiterated Stifel Buy $10 → $14
Dec-08-15Reiterated Jefferies Buy $15 → $18
Sep-21-15Reiterated Jefferies Buy $7 → $15
Jun-09-15Initiated Guggenheim Buy
Jul-08-14Initiated FBR Capital Outperform $34
Apr-17-14Reiterated Noble Financial Buy $9 → $13
Jan-28-14Reiterated Noble Financial Buy $7.25 → $9
Nov-01-13Initiated Stifel Buy $8
Jun-28-20 09:41AM  
Jun-25-20 04:49PM  
Jun-01-20 06:50AM  
May-27-20 09:47AM  
May-25-20 09:36PM  
May-08-20 06:50AM  
May-07-20 12:00AM  
May-06-20 09:35AM  
Apr-29-20 03:00PM  
Apr-28-20 06:50AM  
Apr-27-20 12:32PM  
Apr-22-20 06:50AM  
Mar-27-20 08:02AM  
Mar-26-20 04:05PM  
Mar-24-20 07:45AM  
Mar-16-20 06:00AM  
Mar-12-20 11:21AM  
Mar-11-20 06:25PM  
Mar-03-20 12:56PM  
Feb-24-20 08:30AM  
Feb-20-20 08:15AM  
Feb-13-20 12:31PM  
Feb-10-20 06:30AM  
Feb-03-20 06:30AM  
Jan-15-20 10:37AM  
Jan-07-20 06:30AM  
Jan-06-20 06:55AM  
Dec-30-19 06:55AM  
Dec-16-19 02:02PM  
Nov-26-19 07:30AM  
Nov-23-19 01:08AM  
Nov-22-19 08:26AM  
Nov-12-19 07:00AM  
Nov-06-19 07:05PM  
Nov-04-19 10:37AM  
Nov-01-19 04:05PM  
Oct-30-19 05:05PM  
Oct-29-19 04:05PM  
Oct-24-19 07:46PM  
Oct-23-19 04:45PM  
Oct-11-19 07:00AM  
Oct-10-19 06:45AM  
Oct-08-19 11:55AM  
Oct-07-19 08:34AM  
Sep-26-19 07:00AM  
Sep-24-19 07:00AM  
Sep-18-19 06:30AM  
Sep-04-19 10:05AM  
Aug-21-19 10:06AM  
Aug-20-19 09:13PM  
Aug-12-19 07:15PM  
Aug-07-19 04:00PM  
Aug-06-19 10:24PM  
Jul-25-19 07:00AM  
Jul-22-19 10:31AM  
Jul-16-19 08:21AM  
Jun-14-19 06:08PM  
Jun-12-19 07:25AM  
Jun-10-19 09:39AM  
Jun-07-19 07:15AM  
May-29-19 07:00AM  
May-08-19 07:00AM  
May-07-19 02:06PM  
May-06-19 10:14PM  
May-03-19 10:38AM  
May-02-19 07:20AM  
Apr-29-19 07:00AM  
Apr-25-19 10:33AM  
Apr-24-19 04:10PM  
Apr-17-19 07:05AM  
Apr-12-19 12:08PM  
Apr-06-19 08:03AM  
TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; and TX-00THR and TX-0008HR, which are transdermal patch product candidates. The company's clinical development product is TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription prenatal vitamin and hormone therapy drug products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. is headquartered in Boca Raton, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Collins Cooper C.DirectorJun 09Buy1.4547,50068,875140,000Jun 10 04:25 PM
Finizio Robert GCEOJun 09Buy1.4446,00066,36018,401,964Jun 10 04:06 PM
Collins Cooper C.DirectorJun 08Buy1.4526,50038,42592,500Jun 10 04:25 PM
Finizio Robert GCEOJun 05Buy1.1530,00034,60018,355,964Jun 08 04:07 PM
Thompson Tommy GDirectorJun 04Buy1.138,7009,831699,600Jun 08 04:12 PM
BISARO PAULDirectorJun 04Buy1.1450,00057,00050,000Jun 08 04:10 PM
Krassan MitchellChief Strategy OfficerFeb 03Option Exercise0.20300,00059,387300,000Feb 05 06:07 PM
Krassan MitchellChief Strategy OfficerFeb 03Sale2.26300,000676,9200Feb 05 06:07 PM
Milligan John C.K. IVPresident/SecretaryOct 25Buy2.7572,000198,0001,544,419Oct 29 05:03 PM
Bernick BrianDirectorOct 25Buy2.7536,00099,00098,000Oct 29 04:56 PM
Milligan John C.K. IVPresident/SecretaryOct 25Buy2.7572,000198,0001,544,419Oct 29 05:01 PM
Finizio Robert GCEOOct 25Buy2.7572,000198,00018,325,964Oct 29 04:55 PM
Russell Angus C.DirectorAug 23Buy2.7710,00027,70093,500Aug 26 05:14 PM
Finizio Robert GCEOAug 20Buy2.7435,00095,90018,253,964Aug 20 05:12 PM
Milligan John C.K. IVPresident/SecretaryAug 16Buy2.9310,00029,3003,582,373Aug 19 04:56 PM
Russell Angus C.DirectorAug 15Buy2.9910,00029,90083,500Aug 15 04:33 PM
Russell Angus C.DirectorAug 14Buy2.7625,00069,00073,500Aug 15 04:33 PM
Milligan John C.K. IVPresident/SecretaryAug 12Buy3.1615,00047,4003,572,373Aug 14 04:32 PM
Barlow Jane FDirectorAug 12Buy3.183,1449,9983,144Aug 14 04:33 PM
Thompson Tommy GDirectorAug 09Buy3.045,00015,200690,900Aug 13 04:33 PM
Bernick BrianDirectorAug 09Buy2.8710,00028,70062,000Aug 13 04:31 PM
Finizio Robert GCEOAug 09Buy2.9652,405155,11918,218,964Aug 12 05:32 PM